Agnes Malysa

The Barbara Ann Karmanos Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53”.

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53

Cell Death and Disease(2020)10.1038/s41419-020-2519-8

N/A

0DataRank · unranked

77 citations

Mu Zhang, Niko Moses, Cong-li Hu, Lisa Polin, Wei Chen +13 more

Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment

Scientific Reports(2022)10.1038/s41598-022-14788-5

N/A

0DataRank · unranked

15 citations

Lisa Rubinsak, Agnes Malysa, Sijana H. Dzinic, Manasa Ravindra, Mathew Schneider +11 more

Ribonucleotide reductase M1 regulates the cell cycle via minichromosome maintenance proteins

Genes & Diseases(2025)10.1016/j.gendis.2025.101927

N/A

0DataRank · unranked

0 citations

Jenny Kreahling, Scott N. Freeman, Bin Bao, Jiawei Zhao, Xiaohong Zhang +3 more